Cargando…

Fibroblast growth factor 21 and prognosis of patients with cardiovascular disease: A meta-analysis

BACKGROUND: The role of fibroblast growth factor 21 (FGF21) in predicting the long-term prognosis of patients with cardiovascular disease (CVD) remains unknown. METHODS: A comprehensive search in PubMed, Embase, and the Cochrane Library was performed to identify studies reporting the association bet...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yan, Bing, Ma, Sicong, Yan, Chenghui, Han, Yaling
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10011636/ https://www.ncbi.nlm.nih.gov/pubmed/36926038 http://dx.doi.org/10.3389/fendo.2023.1108234

Ejemplares similares

Fibroblast growth factor 21 in metabolic syndrome
por: Yang, Ming, et al.
Publicado: (2023)

The Role of Fibroblast Growth Factor 21 in Diabetic Cardiovascular Complications and Related Epigenetic Mechanisms
por: Xiao, Mengjie, et al.
Publicado: (2021)

Fibroblast Growth Factor 21 Analogs for Treating Metabolic Disorders
por: Zhang, Jun, et al.
Publicado: (2015)

Independent Association of Serum Fibroblast Growth Factor 21 Levels With Impaired Liver Enzymes in Hyperthyroid Patients
por: Xiao, Fangsen, et al.
Publicado: (2019)

Circulating Fibroblast Growth Factor 21 and Total Testosterone in Type 2 Diabetes Mellitus Men With Coronary Heart Disease
por: Mei, Yufeng, et al.
Publicado: (2022)

Adapting to the Cold: A Role for Endogenous Fibroblast Growth Factor 21 in Thermoregulation?
por: Klein Hazebroek, Marlou, et al.
Publicado: (2020)

Fibroblast Growth Factor 21-Null Mice Do Not Exhibit an Impaired Response to Fasting
por: Antonellis, Patrick Joseph, et al.
Publicado: (2016)

Bifidobacterium adolescentis Alleviates Liver Steatosis and Steatohepatitis by Increasing Fibroblast Growth Factor 21 Sensitivity
por: Long, Xiaoxue, et al.
Publicado: (2021)

SAT-046 Insulin-Like Growth Factor and Fibroblast Growth Factor 21 in Men with Klinefelter Syndrome
por: Chang, Simon, et al.
Publicado: (2020)

Basic Fibroblast Growth Factor Predicts Cardiovascular Disease Occurrence in Participants from the Veterans Affairs Diabetes Trial
por: Zimering, Mark B., et al.
Publicado: (2013)

Fibroblast growth factor-23 and cardiovascular disease among prevalent hemodialysis patients focusing on residual kidney function
por: Kee, Youn Kyung, et al.
Publicado: (2023)

Fibroblast Growth Factor-21 to Adiponectin Ratio: A Potential Biomarker to Monitor Liver Fat in Children With Obesity
por: Tas, Emir, et al.
Publicado: (2020)

Fibroblast Growth Factor 21 Levels Exhibit the Association With Renal Outcomes in Subjects With Type 2 Diabetes Mellitus
por: Chang, Li-Hsin, et al.
Publicado: (2022)

SAT-255 Evaluation of Uncoupling Protein 1 and Fibroblast Growth Factor 21 in Obese Adolescents
por: Pamuk, Gizem, et al.
Publicado: (2019)

Role of Fibroblast Growth Factor-23 in Innate Immune Responses
por: Fitzpatrick, Elizabeth A., et al.
Publicado: (2018)

Plasma Levels of Myonectin But Not Myostatin or Fibroblast-Derived Growth Factor 21 Are Associated with Insulin Resistance in Adult Humans without Diabetes Mellitus
por: Toloza, Freddy J. K., et al.
Publicado: (2018)

Fibroblast Growth Factor Signaling in Metabolic Regulation
por: Nies, Vera J. M., et al.
Publicado: (2016)

Physiological Actions of Fibroblast Growth Factor-23
por: Erben, Reinhold G.
Publicado: (2018)

Upstream Regulators of Fibroblast Growth Factor 23
por: Ratsma, Danielle M. A., et al.
Publicado: (2021)

Spinal Cord Injury Reduces Serum Levels of Fibroblast Growth Factor-21 and Impairs Its Signaling Pathways in Liver and Adipose Tissue in Mice
por: Liu, Xin-Hua, et al.
Publicado: (2021)

Fibroblast Growth Factor 19 in Gestational Diabetes Mellitus and Fetal Growth
por: Yang, Meng-Nan, et al.
Publicado: (2022)

Fibroblast growth factor 21 and bone homeostasis
por: Tang, Yan, et al.
Publicado: (2023)

Emerging roles of fibroblast growth factor 21 in critical disease
por: Yan, Fang, et al.
Publicado: (2022)

Direct and indirect effects of fibroblast growth factor 23 on the heart
por: Nakano, Toshiaki, et al.
Publicado: (2023)

Fibroblast Growth Factor 1 Promotes Rat Stem Leydig Cell Development
por: Chen, Lanlan, et al.
Publicado: (2019)

High-Level Serum Fibroblast Growth Factor 21 Concentration Is Closely Associated With an Increased Risk of Cardiovascular Diseases: A Systematic Review and Meta-Analysis
por: Zhang, Yucong, et al.
Publicado: (2021)

Disruption of the Suprachiasmatic Nucleus in Fibroblast Growth Factor Signaling-Deficient Mice
por: Miller, Ann V., et al.
Publicado: (2016)

Fibroblast Growth Factor in Diabetic Foot Ulcer: Progress and Therapeutic Prospects
por: Liu, Ye, et al.
Publicado: (2021)

Fibroblast growth factor 23 is independently associated with renal magnesium handling in patients with chronic kidney disease
por: Grigore, Teodora V., et al.
Publicado: (2023)

Body-Weight Fluctuation Was Associated With Increased Risk for Cardiovascular Disease, All-Cause and Cardiovascular Mortality: A Systematic Review and Meta-Analysis
por: Zou, Huajie, et al.
Publicado: (2019)

Targeting Fibroblast Growth Factor 23 Signaling with Antibodies and Inhibitors, Is There a Rationale?
por: Fukumoto, Seiji
Publicado: (2018)

Fibroblast growth factor 21 ameliorates neurodegeneration in rat and cellular models of Alzheimer’s disease
por: Chen, Song, et al.
Publicado: (2019)

Fibroblast growth factor 21 is expressed and secreted from skeletal muscle following electrical stimulation via extracellular ATP activation of the PI3K/Akt/mTOR signaling pathway
por: Arias-Calderón, Manuel, et al.
Publicado: (2023)

Efficacy and Safety of Hybrid Comprehensive Telerehabilitation (HCTR) for Cardiac Rehabilitation in Patients with Cardiovascular Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Yang, Zheming, et al.
Publicado: (2023)

Fibroblast Growth Factor-1 Activates Neurons in the Arcuate Nucleus and Dorsal Vagal Complex
por: Roberts, Brandon L., et al.
Publicado: (2021)

The Role of Fibroblast Growth Factor 19 Subfamily in Different Populations Suffering From Osteoporosis
por: Yu, Xiawen, et al.
Publicado: (2022)

Augmented Fibroblast Growth Factor-23 Secretion in Bone Locally Contributes to Impaired Bone Mineralization in Chronic Kidney Disease in Mice
por: Andrukhova, Olena, et al.
Publicado: (2018)

Impact of Altered Mineral Metabolism on Pathological Cardiac Remodeling in Elevated Fibroblast Growth Factor 23
por: Leifheit-Nestler, Maren, et al.
Publicado: (2018)

Fibroblast Growth Factor 19 Levels Predict Subclinical Atherosclerosis in Men With Type 2 Diabetes
por: Hu, Jingyi, et al.
Publicado: (2020)

Exploring the correlation between serum fibroblast growth factor-21 levels and Sarcopenia: a systematic review and meta-analysis
por: Liu, Hao, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_6muhe6seklvu9355lsh3rkj2j5